Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated notch 1 transactivate genes by interacting with the cellular protein RBP-Jκ

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 299-306

  Strobl, Lothar J ^a   Höfelmayr, Heike ^a   Stein, Charlotte ^a   Marschall, Gabriele ^a   Brielmeier, Markus ^a   Laux, Gerhard ^a   Bornkamm, Georg W ^a   Zimber Strobl, Ursula ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS ANTIGEN; CELL PROTEIN; EPSTEIN BARR VIRUS ANTIGEN;

ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC RECOMBINATION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS CELL INTERACTION;

EID: 2642594045     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80050-2     Document Type: Article

References (39)

1. RICKINSON, A. B., and E. KIEFF. 1996. Epstein-Barr Virus. In: Fields Virology, Third Edition, edited by FIELDS, B. N., D. M. KNIPE, P. M. HOWLEY, et al., Lippincott-Raven Publishers, Philadelphia, chapter 75, 2397-2446.
2. KIEFF, E. 1996. Epstein-Barr virus and its replication. In: Fields Virology, Third Edition, edited by FIELDS, B. N., D. M., KNIPE, P. M. HOWLEY, et al., Lippincott-Raven Publishers, Philadelphia, chapter 74, 2343-2396.
3. COHEN, J. I., F. WANG, J. MANNICK, and E. KIEFF. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86: 9558-9562.
4. HAMMERSCHMIDT, W. and B. SUGDEN. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
5. KAYE, K. M., K. M. IZUMI, and E. KIEFF. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90: 9150-9154.
6. TOMKINSON, B., E. ROBERTSON, and E. KIEFF. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67: 2014-2025.
7. MANNICK, J. B., J. I. COHEN, M. BIRKENBACH, A. MARCHINI, and E. KIEFF. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65: 6826-6837.
8. BRIELMEIER, M., J. MAUTNER, G. LAUX, and W. HAMMERSCHMIDT. 1996. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J. Gen. Virol. 77: 2807-2818.
9. MILLER, G., J. ROBINSON, L. HESTON, and M. LIPMAN. 1974. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc. Natl. Acad. Sci. USA 71: 4006-4010.
10. CALENDER, A., M. BILLAUD, J. AUBRY, J. BANCHEREAU, M. VUILLAUME, and G. M. LENOIR. 1987. Epstein-Barr virus induces expression of B cell activation markers on in vitro infection of Epstein-Barr virus negative B lymphoma cells. Proc. Natl. Acad. Sci. USA 84: 8060-8064.
11. WANG, F., C. D. GREGORY, M. ROWE, A. B. RICKINSON, D. WANG, M. BIRKENBACH, H. KIKUTANI, T. KISHIMOTO, and E. KIEFF. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA 84: 3452-3456.
12. CORDIER, M., A. CALENDER, M. BILLAUD, U. ZIMBER, G. ROUSSELET, O. PAVLISH, J. BANCHEREAU, T. TURSZ, G. BORNKAMM, and G. M. LENOIR. 1990. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J. Virol. 64: 1002-1013.
13. KNUTSON, J. C. 1990. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. J. Virol. 64: 2530-2536.
14. FAHRAEUS, R., A. JANSSON, A. RICKSTEN, A. SJOBLOM, and L. RYMO. 1990. Epstein-Barr virus encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA 87: 7390-7394.
15. SUNG, N. S., S. KENNEY, D. GUTSCH, and J. S. PAGANO. 1991. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J. Virol. 65: 2164-2169.
16. ZIMBER-STROBL, U., K. O. SUENTZENICH, G. LAUX, D. EICK, M. CORDIER, A. CALENDER, M. BILLAUD, G. M. LENOIR, and G. W. BORNKAMM. 1991. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65: 415-423.
17. TSANG, S. F., F. WANG, K. M. IZUMI, and E. KIEFF. 1991. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. J. Virol. 65: 6765-6771.
18. WANG, F., H. KIKUTANI, S. F. TSANG, T. KISHIMOTO, and E. KIEFF. 1991. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65: 4101-4106.
19. JIN, X. W., and S. H. SPECK. 1992. Identification of critical cis-elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J. Virol. 66: 2846-2852.
20. ZIMBER-STROBL, U., E. KREMMER, F. GRASSER, G. MARSCHALL, G. LAUX, and G. W. BORNKAMM. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12: 167-175.
21. LAUX, G., F. DUGRILLON, C. ECKERT, B. ADAM, U. ZIMBER-STROBL, and G. W. BORNKAMM. 1994. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J. Virol. 68: 6947-6958.
22. MEITINGER, C., L. J. STROBL, G. MARSCHALL, G. W. BORNKAMM, and U. ZIMBER-STROBL. 1994. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element. J. Virol. 68: 7497-7506.
23. GROSSMANN, S. R., E. JOHANNSEN, X. TONG, R. YALAMANCHILI, and E. KIEFF. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91: 7568-7572.
24. HENKEL, T., P. D. LING, S. D. HAYWARD, and M. G. PETERSON. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265: 92-95.
25. WALTZER, L., F. LOGEAT, C. BROU, A. ISRAEL, A. SERGEANT, and E. MANET. 1994. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 13: 5633-5638.
26. ZIMBER-STROBL, U., L. J. STROBL, C. MEITINGER, R. HINRICHS, T. SAKAI, T. FURUKAWA, T. HONJO, and G. W. BORNKAMM. 1994. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J. 13: 4973-4982.
27. HAMAGUCHI, Y., N. MATSUNAMI, Y. YAMAMOTO, and T. HONJO. 1989. Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment. Nucleic. Acids. Res. 17: 9015-9026.
28. MATSUNAMI, N., Y. HAMAGUCHI, Y. YAMAMOTO, K. KUZE, K. KANGAWA, H. MUTSUO, M. KAWAICHI, and T. HONJO. 1989. A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature 342: 934-937.
29. LAUX, G., B. ADAM, L. J. STROBL, and F. MOREAU-GACHELIN. 1994. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J. 13: 5624-5632.
30. FURUKAWA, T., S. MARUYAMA, M. KAWAICHI, and T. HONJO. 1992. The Drosophila homolog of the immunoglobulin recombination signal-binding protein regulates peripheral nervous system development. Cell 69: 1191-1197.
31. SCHWEISGUTH, F. and J. W. POSAKONY. 1992. Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates. Cell 69: 1199-1212.
32. ARTAVANIS-TSAKONAS, S., K. MATSUNO, and M. E. FORTINI. 1995. Notch signaling. Science 268: 225-232.
33. KOPAN, R., J. S. NYE, and H. WEINTRAUB. 1994. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120: 2385-2396.
34. NYE, J. S., R. KOPAN, and R. AXEL. 1994. An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. Development 120: 2421-2430.
35. MILNER. L. A., R. KOPAN, D. I. MARTIN, and I. D. BERNSTEIN. 1994. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood 83: 2057-2062.
36. ROBEY, E., D. CHANG, A. ITANO, D. CADO, H. ALEXANDER, D. LANS, G. WEINMASTER, and P. SALMON. 1996. An activated form of Notch influences the choices between CD4 and CD8 T cell lineages. Cell 87: 483-492.
37. MILNER, L. A., A. BIGAS, R. KOPAN, C. BRASHEM STEIN, I. D. BERNSTEIN, and D. I. MARTIN. 1996. Inhibition of granulocytic differentation by mNotch1. Proc. Natl. Acad. Sci. USA 93: 13014-13019.
38. HSIEH, J. J., T. HENKEL, P. SALMON, E. ROBEY, M. G. PETERSON, and S. D. HAYWARD. 1996. Truncated mammalian Notch1 activates CBF1/RBP Jκ-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell Biol. 16: 952-959.
39. MINOGUCHI, S., Y. TANIGUCHI, H. KATO, T. OKAZAKI, L. J. STROBL, U. ZIMBER-STROBL, G. W. BORNKAMM, and T. HONJO. 1997. RBP-L, a transcription factor related to RBP-Jκ Mol. Cell. Biol. 17: 2679-2687.